/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Bio-Rad Laboratories, Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$320.34 0.0056(0.56%) BIO at 04 Dec 2025 04:26 PM Medical Devices
Lowest Today 317.48
Highest Today 322.5
Today’s Open 321.75
Prev. Close 318.56
52 Week High 373.69
52 Week Low 211.43
Day’s Range: Low 317.48 High 322.5
52-Week Range: Low 211.43 High 373.69
1 day return -
1 Week return -1.23
1 month return +3.09
3 month return +10.68
6 month return +44.39
1 year return -5.25
3 year return -20.87
5 year return -42.56
10 year return -

Institutional Holdings

Arnhold & S. Bleichroeder Advisers, LLC 9.30

First Eagle Global A 6.94

Vanguard Group Inc 6.82

BlackRock Inc 6.51

Dimensional Fund Advisors, Inc. 3.69

Veritas Asset Management LLP 3.19

Ariel Investments, LLC 3.02

Earnest Partners LLC 2.24

iShares Core S&P Mid-Cap ETF 2.24

Vanguard Total Stock Mkt Idx Inv 2.21

State Street Corp 2.16

Vanguard Small Cap Index 1.69

Bank of America Corp 1.67

First Pacific Advisors, LP 1.43

Ariel Fund Investor 1.28

Geode Capital Management, LLC 1.23

Parnassus Investments LLC 1.17

Southeastern Asset Management Inc 1.17

Parnassus Value Equity Fund Composite 1.15

Parnassus Value Equity Investor 1.15

Thompson, Siegel & Walmsley LLC 1.13

Vanguard Small Cap Value Index Inv 1.08

DFA US Small Cap Value I 1.00

Mawer Investment Management Ltd 0.99

SEI Investments Co 0.98

Select Equity Group LP 0.95

EARNEST Partners Smid Cap Core Founders 0.93

Millennium Management LLC 0.93

FPA Contrarian Value 0.90

FPA Crescent 0.90

First Eagle Amundi International AU-C 0.84

Northern Trust Corp 0.84

Deerfield Management Co 0.84

Longleaf Partners 0.81

Vanguard Institutional Extnd Mkt Idx Tr 0.74

DFA US Targeted Value I 0.60

Veritas Global Focus A USD 0.53

SPDR® S&P MIDCAP 400 ETF Trust 0.53

Dimensional US Targeted Value ETF 0.47

Nedgroup Inv Funds Global Equity A Acc 0.41

Market Status

Strong Buy: 2

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 8593.10 M

PB Ratio 1.2873

PE Ratio 0.0

Enterprise Value 8594.37 M

Total Assets 9364.10 M

Volume 271826

Company Financials

Annual Revenue FY24:2566500000 2566.5M, FY23:2720366000 2720.4M, FY22:2802249000 2802.2M, FY21:2922545000 2922.5M, FY20:2545626000 2545.6M

Annual Profit FY24:1378900000 1378.9M, FY23:1457680000 1457.7M, FY22:1567330000 1567.3M, FY21:1640661000 1640.7M, FY20:1437822000 1437.8M

Annual Net worth FY24:-1844200000 -1844.2M, FY23:-159298000 -159.3M, FY22:-3627535000 -3627.5M, FY21:4245902000 4245.9M, FY20:3806267000 3806.3M

Quarterly Revenue Q3/2025:653000000 653.0M, Q2/2025:651600000 651.6M, Q1/2025:585400000 585.4M, Q4/2024:667500000 667.5M, Q3/2024:649729000 649.7M

Quarterly Profit Q3/2025:343400000 343.4M, Q2/2025:345300000 345.3M, Q1/2025:306000000 306.0M, Q4/2024:342000000 342.0M, Q3/2024:355903000 355.9M

Quarterly Net worth Q3/2025:-341900000 -341.9M, Q2/2025:317800000 317.8M, Q1/2025:64000000 64.0M, Q4/2024:-715800000 -715.8M, Q3/2024:653172000 653.2M

Fund house & investment objective

Company Information Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Organisation Medical Devices

Employees 7700

Industry Medical Devices

CEO Mr. Norman D. Schwartz

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow